IShares NASDAQ US Biotechnology UCITS ETF
Pagina dedicata companiei iShares NASDAQ US Biotechnology UCITS ETF listata cu simbolul DE.2B70
Descriere companieModificare
The Nasdaq Biotechnology index tracks Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease. The dividends in the fund are reinvested (accumulating).
The total expense ratio amounts to 0.35% p.a.. The fund replicates the performance of the underlying index by buying a selection of the most relevant index constituents (sampling technique). The iShares Nasdaq US Biotechnology UCITS ETF has 322m GBP assets under management. The ETF is older than 3 years and is domiciled in Ireland.
Grafic actiuni companieModificare